Reuters logo
Mylan narrows full-year revenue, profit forecast
August 7, 2014 / 10:51 AM / 3 years ago

Mylan narrows full-year revenue, profit forecast

Aug 7 (Reuters) - Generic drug maker Mylan Inc narrowed its full-year revenue and earnings forecast, citing delays in U.S. Food and Drug Administration approval of key products.

The company narrowed its revenue forecast range to $7.8 billion-$8 billion from $7.8 billion-$8.2 billion.

Mylan also narrowed its full-year earnings forecast range to $3.25-$3.45 per share from $3.25-$3.60. (Reporting by Natalie Grover in Bangalore; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below